Imaging in pulmonary medicine

2007 ◽  
pp. 3-6
Keyword(s):  
Pulmonary Medicine

Cost-minimization analysis of drugs used in the treatment of Asthma and COPD diseases in India

2020 ◽  
Vol 15 ◽  
Author(s):  
Billu Payal ◽  
Anoop Kumar ◽  
Harsh Saxena
Keyword(s):  
Generic Drugs ◽  
Cost Minimization ◽  
Cost Savings ◽  
Chronic Obstructive ◽  
Pulmonary Medicine ◽  
Potential Cost ◽  
Maximum Cost ◽  
Cost Minimization Analysis ◽  
Cost Variation ◽  
The Cost

Background: Asthma and Chronic Obstructive Pulmonary Diseases (COPD) are well known respiratory diseases affecting millions of peoples in India. In the market, various branded generics, as well as generic drugs, are available for their treatment and how much cost will be saved by utilizing generic medicine is still unclear among physicians. Thus, the main aim of the current investigation was to perform cost-minimization analysis of generic versus branded generic (high and low expensive) drugs and branded generic (high expensive) versus branded generic (least expensive) used in the Department of Pulmonary Medicine of Era Medical University, Lucknow for the treatment of asthma and COPD. Methodology: The current index of medical stores (CIMS) was referred for the cost of branded drugs whereas the cost of generic drugs was taken from Jan Aushadi scheme of India 2016. The percentage of cost variation particularly to Asthma and COPD regimens on substituting available generic drugs was calculated using standard formula and costs were presented in Indian Rupees (as of 2019). Results: The maximum cost variation was found between the respules budesonide high expensive branded generic versus least expensive branded generic drugs and generic versus high expensive branded generic. In combination, the maximum cost variation was observed in the montelukast and levocetirizine combination. Conclusion: In conclusion, this study inferred that substituting generic antiasthmatics and COPD drugs can bring potential cost savings in patients.

Reactive oxygen species modulators in pulmonary medicine

2021 ◽  
Vol 57 ◽  
pp. 157-164
Author(s):  
Ankush Sharma ◽  
Devesh Tewari ◽  
Seyed Fazel Nabavi ◽  
Seyed Mohammad Nabavi ◽  
Solomon Habtemariam
Keyword(s):  
Reactive Oxygen Species ◽  
Reactive Oxygen ◽  
Pulmonary Medicine ◽  
Oxygen Species

scholarly journals Heme oxygenase-1 and carbon monoxide in pulmonary medicine

2003 ◽  
Vol 4 (1) ◽  
Author(s):  
Dirk-Jan Slebos ◽  
Stefan W Ryter ◽  
Augustine MK Choi
Keyword(s):  
Carbon Monoxide ◽  
Heme Oxygenase ◽  
Heme Oxygenase 1 ◽  
Pulmonary Medicine

Pediatric pulmonary medicine

2014 ◽  
Vol 26 (3) ◽  
pp. 304-305
Author(s):  
David N. Cornfield
Keyword(s):  
Pulmonary Medicine

scholarly journals Regenerative pulmonary medicine: potential and promise, pitfalls and challenges

2012 ◽  
Vol 42 (8) ◽  
pp. 900-913 ◽  
Author(s):  
Piero Anversa ◽  
Mark A. Perrella ◽  
Stella Kourembanas ◽  
Augustine M. K. Choi ◽  
Joseph Loscalzo
Keyword(s):  
Pulmonary Medicine

scholarly journals Mesenchymal stem cells for therapeutic applications in pulmonary medicine

2015 ◽  
Vol 115 (1) ◽  
pp. 45-56 ◽  
Author(s):  
Collin T. Stabler ◽  
Shimon Lecht ◽  
Philip Lazarovici ◽  
Peter I. Lelkes
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Pulmonary Medicine ◽  
Therapeutic Applications

A New Paradigm for Pulmonary Medicine

CHEST Journal ◽  
1998 ◽  
Vol 114 (4) ◽  
pp. 951-952 ◽  
Author(s):  
Thomas L. Petty ◽  
Thomas L. Petty
Keyword(s):  
Pulmonary Medicine ◽  
New Paradigm
Sign in / Sign up

Export Citation Format

Share Document